Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 3/20 | 0.44 |
| ▸ | HTR4 | Q13639 | 5/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | HRH2 | P25021 | 4/20 | 0.40 |
| ▸ | HRH1 | P35367 | 4/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14216100 | 0.96 | HRH2 (0.45) | CACNA1BHTR4HRH2HRH1MCHR1 | |
| SCHEMBL10144478 | 0.86 | CACNA1B (0.49) | CACNA1BHTR4HRH1 | |
| SCHEMBL10143828 | 0.85 | HTR4 (0.49) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL13543471 | 0.85 | HTR4 (0.45) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL14194928 | 0.81 | HTR4 (0.48) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL14194645 | 0.81 | HTR4 (0.48) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL13261137 | 0.81 | MCHR1 (0.47) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL10144544 | 0.81 | MCHR1 (0.47) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL10143839 | 0.79 | HTR4 (0.55) | HTR4CHRM4CHRM5ADRA2CCHRM3 | |
| SCHEMBL13667333 | 0.79 | HTR4 (0.49) | HTR4CHRM4CHRM5ADRA2CCHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079743-B1 | PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | CHROMA THERAPEUTICS LTD (GB) | 2012-01-25 | — | — | EP | disclosed |
| WO-2008050096-A1 | PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | CHROMA THERAPEUTICS LTD. (GB) | 2008-05-02 | — | — | WO | disclosed |